Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).

Source:http://linkedlifedata.com/resource/pubmed/id/6327515

Download in:

View as

General Info

PMID
6327515